2018, Number 2
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2018; 16 (2)
Necrolytic Migratory Erythema as First Manifestation of Glucagonoma Syndrome
Villela-Segura U, Guevara-Sanginés E
Language: Spanish
References: 10
Page: 142-144
PDF size: 152.29 Kb.
ABSTRACT
The necrolytic migratory erythema (nme) represents an entity
whose most common association is glucagonoma, a pancreatic
tumor derived from alpha cells, the association of these two entities
plus a long standing diarrhea and diabetes, is called glucagonoma
syndrome; an extremely rare entity, with an estimated
incidence of one case per 20 million people. We present a 46
year-old Mexican women, presenting with nme as only clinical
finding, where both clinical and pathological correlation were
crucial for diagnosis of glucagonoma.
REFERENCES
Tremblay C y Marcil I, Necrolytic migratory erythema: a forgotten paraneoplastic condition, J Cutan Med Surg 2017; 1:1203475417719051
Al-Faouri A, Ajarma K, Alghazawi S et al., Glucagonoma and glucagonoma syndrome: a case report with review of recent advances in management, Case Rep Surg 2016; 16:1484-89.
Han X, Wang D, Kuang T et al., Glucagonoma syndrome: report of one case, Transl Gastroenterol Hepatol 2016; 1:70.
Wu S, Bai J, Xu J et al., Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor, World J Surg Oncol 2014; 12:220.
Gronau M, Jäger D, Enk AH et al., Necrolytic migratory erythema in a patient with neuroendocrine carcinoma, Intern Med 2013; 52:151-2.
John AM y Schwartz RA, Glucagonoma syndrome: a review and update on treatment, J Eur Acad Dermatol Venereol 2016; 30:2016-22.
Tseng HC, Liu CT, Ho JC et al., Necrolytic migratory erythema and glucagonoma rising from pancreatic head, Pancreatology 2013; 13:455-7.
Thomaidou E, Nahmias A, Gilead L et al., Rapid clearance of necrolytic migratory erythema following intravenous administration of amino acids, jama Dermatol 2016; 152:345-6.
Kimbara S, Fujiwara Y, Toyoda M et al., Rapid improvement of glucagonoma- related necrolytic migratory erythema with octreotide, Clin J Gastroenterol 2014; 7:255-9.
Luber AJ, Ackerman LS, Culpepper KS et al., Paediatric necrolytic migratory erythema as a presenting sign of glucagonoma syndrome, Br J Dermatol 2016; 174:1092-95.